ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #14,545Hybrid

Biomedical Research-Tokyo

Abbreviation (ISO):BIOMED RES-TOKYO
•
Identifier (ISSN):0388-6107(Print)/1880-313X(Online)
•
Publisher:Biomedical Research Foundation
Clarivate IF (2026)
1.5↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Biomedical Research-Tokyo

WoS Q4
01341.2820181.2220191.4320201.220212.9620221.220231.320241.320251.52026
Annual Impact Factor Metric
Current (2026):1.5
Scopus SJR & RankScopus Q3
0.387
#14,545

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
46

46 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate7.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
28articles/year
79.22% Gold OA•86.96% Original Research

Aims & Scope

Biomedical Research is peer-reviewed International Research Journal . It was first launched in 1990 as a biannual English Journal and later became triannual. From 2008 it is published in Jan-Apr/ May-Aug/ Sep-Dec..

Topics Covered (Recognized by AI)
Biology98.5%Medicine91.8%Chemistry89.1%Internal medicine81.9%Biochemistry80.2%Genetics75.6%Endocrinology61.5%Cell biology36.6%Organic chemistry33.6%Physics33.4%Pathology31.4%Immunology28.5%Psychology28.2%Receptor27.1%Gene24.8%Neuroscience23.6%Nuclear magnetic resonance22.5%Anatomy21.1%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q4
Rank146/191
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q4
Rank144/191
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.5
Articles / Year16
Total Citations0
2025
IF1.3
Articles / Year29
Total Citations36
2024
IF1.3
Articles / Year25
Total Citations100
2023
IF1.2
Articles / Year24
Total Citations90
2022
IF2.964
Articles / Year23
Total Citations121

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #14,545Scopus Q3SCImago Profile
Scopus Coverage:1980-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q3
0.387

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.45

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,776 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations100
3-Year Documents72
Citable Documents72

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate32.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q3
Medicine (miscellaneous)Q3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 7.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区MEDICINE, RESEARCH & EXPERIMENTAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Biomedical Research-Tokyo (abbr: BIOMED RES-TOKYO, ISSN: 0388-6107) is a peer-reviewed international scholarly journal in the field of Medicine, published by Biomedical Research Foundation in Japan since 1980. The periodical holds a Journal Impact Factor (JIF) of 1.50, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.387 (Q3), an H-index of 46.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 28 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,776 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Biomedical Research Foundation
Publication Language
English
Frequency
Bimonthly
Founding Year
1980
Indexing & Databases
SCIEScopusPubMed
Editorial Address
BIOMEDICAL RESEARCH PRESS LTD, HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, JAPAN, 060-8638

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 77bdeac1-71e2-4e10-86e5-b50b1d95d52c
Database Updated: 2026-10-01